Overbeck, Tobias R.

[["dc.bibliographiccitation.journal","Lung Cancer"],["dc.bibliographiccitation.volume","49"],["dc.contributor.author","Griesinger, Frank"],["dc.contributor.author","Overbeck, Tobias R."],["dc.contributor.author","Schondube, F."],["dc.contributor.author","Schmidtberger, H."],["dc.contributor.author","Andreas, S."],["dc.contributor.author","Schirren, J."],["dc.contributor.author","Hemmerlein, Bernhard"],["dc.contributor.author","Keppler, U."],["dc.contributor.author","Leupold, H."],["dc.contributor.author","Baum, R."],["dc.date.accessioned","2018-11-07T09:26:18Z"],["dc.date.available","2018-11-07T09:26:18Z"],["dc.date.issued","2005"],["dc.format.extent","S26"],["dc.identifier.doi","10.1016/S0169-5002(05)80201-6"],["dc.identifier.isi","000231307800076"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/30268"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Elsevier Ireland Ltd"],["dc.publisher.place","Clare"],["dc.relation.conference","11th World Conference on Lung Cancer"],["dc.relation.eventlocation","Barcelona, SPAIN"],["dc.relation.issn","0169-5002"],["dc.title","Phase II induction therapy with docetaxel and carboplatin in NSCLC IIIA/IIIB: FDG-PET response predicts overall and disease free survival"],["dc.type","conference_abstract"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.issue","9"],["dc.bibliographiccitation.journal","Journal of Thoracic Oncology"],["dc.bibliographiccitation.volume","10"],["dc.contributor.author","Griesinger, Frank"],["dc.contributor.author","Sebastian, Martin"],["dc.contributor.author","Serke, Monika Heidi"],["dc.contributor.author","Grohe, Christian"],["dc.contributor.author","Hillejan, Lars"],["dc.contributor.author","Passlick, Bernward"],["dc.contributor.author","Reinmuth, Nils"],["dc.contributor.author","Graeven, Ullrich"],["dc.contributor.author","Lueers, Anne C."],["dc.contributor.author","Radke, Susanne M."],["dc.contributor.author","Karatas, Aysun"],["dc.contributor.author","Tiemann, Markus"],["dc.contributor.author","Heukamp, Lukas"],["dc.contributor.author","Overbeck, Tobias R."],["dc.date.accessioned","2018-11-07T09:51:51Z"],["dc.date.available","2018-11-07T09:51:51Z"],["dc.date.issued","2015"],["dc.format.extent","S564"],["dc.identifier.isi","000370365102534"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/35996"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Elsevier Science Inc"],["dc.publisher.place","New york"],["dc.relation.issn","1556-1380"],["dc.relation.issn","1556-0864"],["dc.title","Induction Therapy with Intercalated TKI and Chemotherapy in NSCLC with Activating EGFR Mutation in Stages II-IIIB: NeoIntercal"],["dc.type","conference_abstract"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.journal","Oncology Research and Treatment"],["dc.bibliographiccitation.volume","38"],["dc.contributor.author","Griesinger, Frank"],["dc.contributor.author","Sebastian, Martin"],["dc.contributor.author","Serke, Monika Heidi"],["dc.contributor.author","Buettner, Reinhardt"],["dc.contributor.author","Waller, C."],["dc.contributor.author","Reinmuth, Nils"],["dc.contributor.author","Graeven, Ullrich"],["dc.contributor.author","Lueers, Anne C."],["dc.contributor.author","Radke, Susanne M."],["dc.contributor.author","Karatas, Aysun"],["dc.contributor.author","Heukamp, Lukas Carl"],["dc.contributor.author","Tiemann, Markus"],["dc.contributor.author","Overbeck, Tobias R."],["dc.date.accessioned","2018-11-07T09:50:37Z"],["dc.date.available","2018-11-07T09:50:37Z"],["dc.date.issued","2015"],["dc.format.extent","140"],["dc.identifier.isi","000364268800331"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/35741"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Karger"],["dc.publisher.place","Basel"],["dc.relation.issn","2296-5262"],["dc.relation.issn","2296-5270"],["dc.title","Induction therapy with intercalated TKI and chemotherapy in NSCLC with activating EGFR mutation in stages II-IIIB: Neolntercal"],["dc.type","conference_abstract"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","2"],["dc.bibliographiccitation.journal","Onkologie"],["dc.bibliographiccitation.lastpage","4"],["dc.bibliographiccitation.volume","36"],["dc.contributor.author","Overbeck, Tobias R."],["dc.contributor.author","Schaeper, Christoph"],["dc.contributor.author","Griesinger, Frank"],["dc.contributor.author","Groescheld, Andreas"],["dc.contributor.author","Haug, Alexander"],["dc.contributor.author","Leschber, Gunda"],["dc.contributor.author","Pfluger, Thomas"],["dc.contributor.author","Poettgen, Christoph"],["dc.date.accessioned","2018-11-07T09:20:39Z"],["dc.date.available","2018-11-07T09:20:39Z"],["dc.date.issued","2013"],["dc.identifier.isi","000324083200002"],["dc.identifier.pmid","24162624"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/28929"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Karger"],["dc.relation.issn","0378-584X"],["dc.title","Tumor Conference I"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","2096"],["dc.bibliographiccitation.issue","41"],["dc.bibliographiccitation.journal","DMW - Deutsche Medizinische Wochenschrift"],["dc.bibliographiccitation.lastpage","2100"],["dc.bibliographiccitation.volume","139"],["dc.contributor.author","Sebastian, Martin"],["dc.contributor.author","Niederle, N."],["dc.contributor.author","Thomas, M."],["dc.contributor.author","Reck, Martin"],["dc.contributor.author","Schmittel, A."],["dc.contributor.author","Fischer, B."],["dc.contributor.author","Overbeck, Tobias R."],["dc.contributor.author","Groeschel, Andreas"],["dc.contributor.author","Deppermann, M."],["dc.contributor.author","Pirker, R."],["dc.contributor.author","Huber, R. M."],["dc.contributor.author","Eberhardt, W."],["dc.contributor.author","Griesinger, Frank"],["dc.date.accessioned","2018-11-07T09:34:31Z"],["dc.date.available","2018-11-07T09:34:31Z"],["dc.date.issued","2014"],["dc.identifier.doi","10.1055/s-0034-1387294"],["dc.identifier.isi","000342982400011"],["dc.identifier.pmid","25268213"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/32185"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Georg Thieme Verlag Kg"],["dc.relation.issn","1439-4413"],["dc.relation.issn","0012-0472"],["dc.title","Molecular genetic tests in advanced non-small cell lung cancer: practical relevance"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dc.type.subtype","letter_note"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.journal","British Journal of Cancer"],["dc.bibliographiccitation.volume","89"],["dc.contributor.author","Overbeck, Tobias R."],["dc.contributor.author","Griesinger, Frank"],["dc.date.accessioned","2018-11-07T10:34:16Z"],["dc.date.available","2018-11-07T10:34:16Z"],["dc.date.issued","2003"],["dc.format.extent","S31"],["dc.identifier.isi","000188229500035"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/44821"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Nature Publishing Group"],["dc.publisher.place","London"],["dc.relation.conference","Iressa Clinical Experience (ICE) Meeting"],["dc.relation.eventlocation","MADRID, SPAIN"],["dc.relation.issn","0007-0920"],["dc.title","Response and symptom improvement with gefitinib ('Iressa', ZD1839) 250 mg day(-1) in a patient with poor performance status"],["dc.type","conference_abstract"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.issue","16"],["dc.bibliographiccitation.journal","Journal of Clinical Oncology"],["dc.bibliographiccitation.volume","23"],["dc.contributor.author","Griesinger, Frank"],["dc.contributor.author","Overbeck, Tobias R."],["dc.contributor.author","Dorge, H."],["dc.contributor.author","Schmidberger, Heinz"],["dc.contributor.author","Meller, J."],["dc.contributor.author","Andreas, S."],["dc.contributor.author","Keppler, U."],["dc.contributor.author","Schirren, J."],["dc.contributor.author","Hemmerlein, Bernhard"],["dc.contributor.author","Baum, R. P."],["dc.date.accessioned","2018-11-07T10:47:47Z"],["dc.date.available","2018-11-07T10:47:47Z"],["dc.date.issued","2005"],["dc.format.extent","666S"],["dc.identifier.isi","000230326604300"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/48045"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Amer Soc Clinical Oncology"],["dc.publisher.place","Alexandria"],["dc.relation.conference","41st Annual Meeting of the American-Society-of-Clinical-Oncology"],["dc.relation.eventlocation","Orlando, FL"],["dc.relation.issn","1527-7755"],["dc.relation.issn","0732-183X"],["dc.title","Phase II induction therapy with docetaxel and carboplatin in NSCLC llIAAIlB: FDG-PET response predicts overall and disease free survival."],["dc.type","conference_abstract"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]